Natixis Advisors, L.P. Artivion, Inc. Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Artivion, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 41,782 shares of AORT stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,782
Previous 12,615
231.21%
Holding current value
$1.69 Million
Previous $310,000
319.03%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.1MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$269 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$120 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$113 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$113 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$93.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.63B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...